3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
6
Acute Kidney Injury
2
Personal Satisfaction
1
Patient Satisfaction
1
Patient Preference
1
Interventions
delta 24-sterol reductase
1
daratumumab
1
Validation Studies as Topic
1
Tape Recording
1
Sorafenib
1
Pilot Projects
1
Focus Groups
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Patient Preference
×
daratumumab
×
Clear all
NCT05284591
2024-10-01
MYLENE
iOMEDICO AG
Completed
96 enrolled